Serum von Willebrand factor for early diagnosis of lung adenocarcinoma in patients with type 2 diabetes mellitus

BACKGROUND: The elevation of plasma von Willebrand factor (vWF) has been proposed to be a predictor of lung cancer. Type 2 diabetes mellitus (T2DM) causes endothelial activation, resulting in the secretion of vWF. However, the role of vWF in patients with T2DM complicated with lung cancer remains un...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ying-Yi, Du, Xuan, Tang, Jia-Li, Wang, Qiu-Ping, Chen, Ke, Shi, Bi-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262717/
https://www.ncbi.nlm.nih.gov/pubmed/32518781
http://dx.doi.org/10.12998/wjcc.v8.i10.1916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262717/
https://www.ncbi.nlm.nih.gov/pubmed/32518781
http://dx.doi.org/10.12998/wjcc.v8.i10.1916

Ejemplares similares